article thumbnail

Exploring the Earnings Landscape of Medical Sales Representatives

Rep-Lite

Healthcare professionals come in all forms: pharmaceutical sales reps, surgical sales reps, biotech sales reps, etc. However, for this exploration, we will be using the umbrella term, medical sales representative. So how much do medical sales reps make? In 2023, sales amounted to about 863 million dollars.

article thumbnail

What Is OEM Sales? With Sean Pitts

Evolve Your Success

OEM Sales is about creating solutions to win customers and making an impact, one deal at a time. In this episode, we have Sean Pitts from GCX corporation to uncover the ins and outs of OEM Sales. Sean discusses the critical qualities that make an exceptional OEM sales representative. If y ou ask, “W hat is OEM sales ?”

Sales 64
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

And so pharma profiteers again

World of DTC Marketing

8 spot ahead of industries such as retail, transportation, and media, and entertainment. BMS believes they price our medicines based on the value they deliver,” but physicians say the price is too high. Drug companies on average spend about 20% of all their sales revenue on R&D. Pharma earned a solid No.

Pharma 191
article thumbnail

Entrance of novel therapies will drive Niemann-Pick type C disease market growth

Pharmaceutical Technology

This sales growth will be in line with a steadily increasing disease prevalence and the entrance of novel agents into the market. The three major markets (3MM: the US, Germany and the UK) will increase in market size from $128.35m last year to $188.35m in 2031, at a compound annual growth rate (CAGR) of 3.9%.

Marketing 122
article thumbnail

T2D market growth driven by novel GLP-1RAs and once-weekly basal insulin therapies

Pharmaceutical Technology

The erosion of Januvia is due to patent expiry in that had been expected in 2022 and physicians’ preference for sodium-glucose linked transporter-2 inhibitor (SGLT-2I) therapies such as Farxiga (dapagliflozin) and Jardiance (empagliflozin) due to their ability to improve glycemic control and address cardiorenal comorbidities.

article thumbnail

From Europe To The U.S.: A Medtech Executive’s Career Chronicle With Fred Colen

Evolve Your Success

If you’re trying to get into the industry, if you work within the industry, and if you’re a sales leader or any kind of leader in the MedTech space, this is a must-read. As always, we do our best to bring you guests who are doing things differently in the medical sales space and I do hope you enjoy this episode. I am very good.

article thumbnail

MedWand Solutions Receives FDA 510k Clearance

Legacy MEDSearch

The award-winning company is currently rolling out its solution through strategic partnerships with major health systems, physician groups, and telehealth companies with the below kits: MedWand Evaluation Kit – Designed for clinical evaluation of the MedWand device and ecosystem. MedWand Solutions, Inc.

FDA 52